TBDCX
Price
$13.29
Change
+$0.06 (+0.45%)
Updated
Aug 21 closing price
Net Assets
443.77M
VIGAX
Price
$270.18
Change
+$1.09 (+0.41%)
Updated
Aug 21 closing price
Net Assets
371.99B
Interact to see
Advertisement

TBDCX vs VIGAX

TBDCX vs VIGAX Comparison Chart in %
View a ticker or compare two or three
VS
TBDCX vs. VIGAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TBDCX is a StrongBuy and VIGAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGAX has more cash in the bank: 372B vs. TBDCX (444M). VIGAX pays higher dividends than TBDCX: VIGAX (0.39) vs TBDCX (0.00). TBDCX was incepted earlier than VIGAX: TBDCX (27 years) vs VIGAX (26 years). TBDCX (1.87) is less costly to investors than VIGAX (0.05). TBDCX is a more actively managed with annual turnover of: 122.00 vs. VIGAX (12.00). TBDCX has a lower initial minimum investment than VIGAX: TBDCX (1000) vs VIGAX (3000). VIGAX annual gain was more profitable for investors over the last year : 16.35 vs. TBDCX (5.23). VIGAX return over 5 years is better than : 75.87 vs. TBDCX (-10.38).
TBDCXVIGAXTBDCX / VIGAX
Total Expense Ratio1.810.053,620%
Annual Report Gross Expense Ratio1.870.053,740%
Fund Existence27 years26 years-
Gain YTD4.8117.58163%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets444M372B0%
Annual Yield % from dividends0.000.39-
Returns for 1 year5.2316.3532%
Returns for 3 years35.6188.5940%
Returns for 5 years-10.3875.87-14%
Returns for 10 years39.02364.8411%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTNM17.191.17
+7.30%
Contineum Therapeutics
MBOT1.500.01
+0.67%
Microbot Medical
HTGC17.130.10
+0.59%
Hercules Capital
MTSI266.610.43
+0.16%
MACOM Technology Solutions Holdings
APVO2.64-0.12
-4.35%
Aptevo Therapeutics Inc